Capricor Therapeutics (CAPR) Current Assets (2010 - 2026)

Capricor Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $283.1 million for Q1 2026.

• In Q1 2026, Current Assets rose 93.56% year-over-year to $283.1 million; the TTM figure through Mar 2026 stood at $283.1 million (up 93.56% YoY), while the FY2025 annual figure was $322.9 million, up 97.66% from the prior year.
• Current Assets was $283.1 million for Q1 2026 at Capricor Therapeutics, down from $322.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $322.9 million in Q4 2025 to a low of $29.5 million in Q3 2023.
• Historically, Current Assets has averaged $98.1 million across 5 years, with a median of $52.6 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Current Assets plunged 37.84% in 2023, then surged 304.73% in 2025.
• A 5-year view of Current Assets shows it stood at $42.9 million in 2022, then advanced by 18.58% to $50.9 million in 2023, then surged by 221.27% to $163.4 million in 2024, then jumped by 97.66% to $322.9 million in 2025, then decreased by 12.34% to $283.1 million in 2026.
• The last three Current Assets figures came in at $283.1 million (Q1 2026), $322.9 million (Q4 2025), and $101.0 million (Q3 2025), per Business Quant data.